$CLMT

Calumet, Inc. /DE (CLMT): Entry into a Material Definitive Agreement

Calumet, Inc. /DE (CLMT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Eleventh Amendment to Third Amended and Restated Credit Agreement On September 11, 2026, Calumet, Inc. (the “Company”) entered into the Eleventh Amendment to the Third Amended and Restated Credit Agreement (the “Eleventh Amend

Original reporting
Published Sep 14, 2026, 9:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 10:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CLMT
Neutral
medium confidence
Mentioned
$CLMT
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CLMTNeutralLow
01

Why it matters

The increased borrowing base may enable new projects or acquisitions, but the immediate market reaction is expected to be muted.

02

Market read

A material credit amendment for a mid‑cap industrial company; limited immediate trading impact but worth monitoring for future financing moves.

03

What to watch

Terms of the amendment, such as covenants or interest rates, are not disclosed and could affect cost of capital.

Relevance 6/10Novelty 7/10Timing: filed Sep 14 2026

Background

SEC Form 8‑K filing details a material amendment to Calumet's credit facility and related monetization agreement.

Company-level read

Ticker impact

$CLMTNeutralMedium confidence
Context

Calumet Inc. filed an 8‑K reporting an Eleventh Amendment to its credit agreement, increasing commitments from $500M to $600M.

Expected impact

Limited immediate impact; price may edge higher if market views increased liquidity positively.

Evidence & confidence

Credit amendment is material but does not change earnings or operations directly; traders may watch for related financing activity.

Market effects

May signal increased financing activity in the specialty chemicals sector.

U.S. market participants may view the amendment as a sign of credit strength for mid‑cap industrial firms.

Limited; primarily affects Calumet and its lenders.

Counterpoint

The amendment could indicate underlying cash flow pressures, suggesting caution.

Key entities

  • Calumet Inc.

    Issuer of the 8‑K filing.

  • Bank of America, N.A.

    Administrative agent for the credit agreement.

  • J. Aron & Company LLC

    Party to the Monetization Master Agreement amendment.

Related articles

$CLMTMed

Calumet stock hits 52-week high at 54.72 USD

Calumet Specialty Products Partners (CLMT) hit a 52-week high of $54.72, up 205.27% over the past year. The company reported Q2 2026 revenue of $1.44B, beating estimates, but missed earnings expectations. S&P upgraded its credit rating to 'B-', while UBS and TD Cowen raised price targets to $47 and $40, respectively, with Neutral/Hold ratings.

$CLMTMed

Q2 Earnings Highlights: Calumet (NASDAQ:CLMT) Vs The Rest Of The Infrastructure Stocks

Calumet (CLMT) stock rose 8.9% post-earnings, trading at $16.19. Kodiak Gas Services (KGS) reported $391.1M revenue, up 21.1% YoY, with stock up 10.5% to $62.81. Excelerate Energy (EE) saw $329.3M revenue, up 61% YoY, with stock up 3% to $39.65. DHT Holdings (DHT) reported $255.2M revenue, up 174% YoY, with stock up 13% to $20.19. Market focus has shifted from AI to geopolitics and back to fundamentals.

$CLMTMed

Why Calumet Stock Topped the Market Today

Calumet (CLMT) stock rose 3% after the EPA granted full exemptions for two refineries, removing 71 million RINs from its balance sheet. The company values remaining RINs at $309 million. Calumet is also seeking exemptions for 2022-2024, which are under review. The exemptions improve its financials by reducing compliance costs.